Phoenix Education Partners, Inc
NYSE:PXEDEducation & Training Services
-$0.42 today
- Market cap
- $754.07M
- Beta
- -0.51
- P/E (TTM)
- 17.6
- EPS (TTM)
- $1.67
- Dividend yield
- 1.42%
Volume 0.20M
Average 0.11M
PXED Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Phoenix Education Partners, IncNYSE: PXED
Research & Development · Q2 FY2026 · quarter ended Feb 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 0 | — |
| FY2024 | 2024-08-31 | 0 | — |
| FY2023 | 2023-08-31 | 0 | — |
Research & Development vs competitors
How PXED compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for PXED, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥634.49M CNY | -1.9% | +12.1% | 10.0% | |
| LTM Jun 2026 | CN¥527.45M CNY | +9.0% | -13.8% | 8.8% | |
| LTM Mar 2026 | $123.4M USD | -2.8% | -9.7% | 15.9% | |
| LTM Jun 2026 | $10.7M USD | -59.8% | — | 0.4% | |
PXEDPhoenix Education Partners, Inc | LTM Feb 2026 | $0 USD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | R$0 BRL | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding PXED) | — | -31.3% | -9.7% | 0.0% | |
Competitors are the stored peer set for PXED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|
| Revenue | 835.25M | 950.02M | 1.01B |
| Cost of Revenue | 379.26M | 403.92M | 435.99M |
| Gross Profit | 455.99M | 546.09M | 571.2M |
| Gross Margin | 54.6% | 57.5% | 56.7% |
| Research & Development | 0 | 0 | 0 |
| Selling, General & Admin | 328.78M | 343.99M | 352.63M |
| Operating Expenses | 328.78M | 343.99M | 352.63M |
| Depreciation & Amortization | 23.91M | 21.06M | 22.01M |
| EBITDA | 113.31M | 189.26M | 204.6M |
| EBITDA Margin | 13.6% | 19.9% | 20.3% |
| Operating Income | 127.2M | 202.1M | 218.57M |
| Operating Margin | 15.2% | 21.3% | 21.7% |
| Interest Income | 8.53M | 16.69M | 10.46M |
| Interest Expense | 1.77M | 960K | 480K |
| Other Income / Expenses | (39.56M) | (34.86M) | (36.46M) |
| Income Before Tax | 87.64M | 167.24M | 182.11M |
| Pre-Tax Margin | 10.5% | 17.6% | 18.1% |
| Income Tax Expense | 21.71M | 52.09M | 46.67M |
| Net Income | 64.93M | 113.13M | 133.88M |
| Net Margin | 7.8% | 11.9% | 13.3% |
| EPS (Basic) | 1.82 | 3.18 | 3.76 |
| EPS (Diluted) | 1.76 | 3.03 | 3.76 |
| Weighted Avg Shares | 35.6M | 35.6M | 35.65M |
| Weighted Avg Shares (Diluted) | 35.6M | 35.6M | 35.65M |
Phoenix Education Partners, Inc
NYSE:PXED
Intrinsic Alpha fair value
Locked
Current Price
$20.56
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.